Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in a healthcare worker population exceeded self-reported infection rates, 2020

A study of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence at a healthcare institution prior to the availability of vaccine showed that seroprevalence in the cohort increased over 6 months from 25% to 55%. The number of employees with antibodies was higher than the number wh...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial stewardship & healthcare epidemiology : ASHE 2022-01, Vol.2 (1), p.e21-e21, Article e21
Main Authors: Hoover, Susan E., Reed, Valerie
Format: Article
Language:English
Subjects:
Antibodies
Cohort analysis
Concise Communication
Coronaviruses
COVID-19
COVID-19 vaccines
Data collection
Disease transmission
Emergency medical care
Employees
Health care
Infections
Long term health care
Medical laboratories
Medical personnel
Obstetrics
Patients
Proteins
Questionnaires
Self report
Serology
Severe acute respiratory syndrome coronavirus 2
Workers
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A study of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence at a healthcare institution prior to the availability of vaccine showed that seroprevalence in the cohort increased over 6 months from 25% to 55%. The number of employees with antibodies was higher than the number who reported an exposure or diagnosis at each time point.
ISSN:2732-494X
2732-494X
DOI:10.1017/ash.2022.9